INTRODUCTION
In the inherited metabolic disorder sialidosis the intralysosomal degradation of sialoglycoconjugates is impaired due to a deficiency of the acid hydrolase neuraminidase (sialidase EC 3.2.1.18) [l-3] .
In galactosialidosis a combined deficiency of neuraminidase and ,8-galactosidase exists [4, 5] . The latter disease is caused by a mutation in the 'protective protein', which protects ,&galactosidase from intralysosomal degradation and is essential for neuraminidase activity [6] . No information is available about the molecular defect in sialidosis.
Active neuraminidase has been isolated from bovine testis and human placenta as a high molecular mass complex with&galactosidase and the protective protein [7, 8] . Partial disruption of the complex with KSCN results in the dissociation of the neuraminidase polypeptide from the complex. The unassociated neuraminidase polypeptide has no enzymatic activity [9] . Reconstitution experiments have shown that, in vitro, association of the neuraminidase polypeptide with the protective protein generates a labile form of neuraminidase activity. This activity is stabilized by ,&galacto-sidase [lo] . Most likely the neuraminidase polypeptide contains the catalytic site. Abbreviations: 
acid; IASA-NeuAQen, 5-Nacetyl-9-(4-iodoazidosalicoylamido)-2-deoxy-2,3-didehydroneuraminic acid; NeuAcZen, 2-deoxy-2,3-didehydro-5-N-acetylneuraminic acid; MU-NeuAc, 2-a-(4-methylumbelliferyl)-5-N-acetylneuraminic acid; SDS, sodium dodecyl sulfate To investigate the catalytic site of neuraminidases, we have recently synthesized the radioiodinatable, photoreactive affinity probe ASA-NeuAQen. This probe was successfully used to label the active site of a bacterial neuraminidase [l 11 . In the present study we have used ASA-NeuAc2en to label the neuraminidase polypeptide in the lysosomal ,&galactosidase/neuraminidase/protective protein complex from bovine testis. 
MATERIALS AND METHODS

RESULTS AND DISCUSSION
To generate optimal conditions for successful photoaffinity labeling of a mammalian lysosomal neuraminidase two considerations were made. First, mammalian neuraminidases are known to be very labile [ 161. We have performed our experiments with the ,8-galactosidase/neuraminidase/protective protein complex isolated from bovine testis [7] , since among the purified lysosomal neuraminidases it is the most stable form available. Secondly, photoaffinity labeling experiments with complex protein mixtures are often hindered by a large extent of non-specific labeling [17] . To reduce non-specific labeling we have used the scavenger ,8-mercaptoethanol [17] . To increase the ratio between specifically and non-specifically labeled proteins we have partially purified the neuraminidase after the labeling reaction.
ASA-NeuAc2en is a derivative of NeuAc2en, a potent competitive inhibitor of mammalian neuraminidases [ 181. To investigate whether introduction of the photoreactive group in NeuAc2en has reduced its affinity for the bovine testis neuraminidase, Ki values for ASA-NeuAc2en and NeuAc2en were compared in kinetic experiments with the purified complex. Under standard assay conditions the K, for 4-MU-NeuAc is 115 PM. The Ki values for ASA-NeuAc2en and NeuAc2en are 21 and 16 PM, respectively (Fig. 1A) . This demonstrates that despite the presence of the arylazide group ASA-NeuAc2en is efficiently recognized by the bovine testis neuraminidase.
To avoid the risk of protein loss due to buffer changes and pH shifts, we have tested whether the label- ing reaction can be performed in the buffer used for the purification of the complex. When kinetic experiments were performed in buffer A (Fig. lB) , the affinity of bovine testis neuraminidase for 4-MU-NeuAc (K, 104 PM), ASA-NeuAc2en (Ki 25 PM), and NeuAc2en (Ki 16 PM) is not altered. Also, addition of the scavenger ,&-mercaptoethanol had no effect on the affinity (data not shown). The ability to perform the photoaffinity labeling reaction in buffer A greatly facilitates the further purification of neuraminidase after labeling. For glycoprotein preparations from human placenta sucrose density gradient centrifugation has been used to With this method the neuraminidase activity can be separated from the majority of ,&galactosidase activity. Purified bovine testis complex was photoaffinitylabeled with [1251]IASA-NeuAc2en and neuraminidase was further purified by sucrose density centrifugation. After SDS-polyacrylamide gel electrophoresis, radiolabeled proteins with molecular masses of 64,55, 32 and 20 kDa were observed (Fig. 3, lane 1) . The pattern corresponds with that of the purified complex after Coomassie staining [7] . The 64 kDa protein is &galac-tosidase, whereas the 32 and 20 kDa proteins are the two polypeptides of the heterodimeric protective protein [7, 19] . When labeling is performed in the presence of the competitive inhibitor NeuAc2en at a concentration that prevents specific labeling (Fig. 3, lane 2) , only labeling of the 55 kDa protein is prevented. Identical results were obtained when total glycoprotein preparations from bovine testis were used, providing that after labeling neuraminidase was further purified by isolation of the complex and sucrose density gradient centrifugation (data not shown). This demonstrates that ASA-NeuAQen can also be used with less pure neuraminidase preparations. We conclude that the 55 l@a protein is the neuraminidase polypeptide, specifically labeled at the active site. This protein is smaller than the 66 kDa neuraminidase polypeptide observed in human placenta [IO] . A comparative biochemical study of both polypeptides is in progress.
After the successful application of ASA-NeuAc2en for the labeling of a bacterial neuraminidase [ 1 I], we have now extended its use for the labeling of a mammalian lysosomal neuraminidase.
ASA-NeuAc2en enables further localization of catalytic site sequences at the peptide level [ Ill. This opens new possibilities for obtaining detailed information about the active site of the lysosomal neuraminidase and the molecular defect in sialidosis.
